Amyloid β protein (Aβ) is the main component of neuritic plaques in Alzheimer's disease
(AD), and its accumulation has been considered as the molecular driver of Alzheimer's …

This decade has seen the beginning of ground-breaking conceptual shifts in the research of
Alzheimer's disease (AD), which acknowledges risk elements and the evolving wide …

The deposition of β-amyloid (Aβ) in the brain is a pathologic hallmark of Alzheimer's disease
(AD), appearing years before the onset of symptoms, and its detection is incorporated into …

Positron emission tomography (PET) with fluorodeoxyglucose (FDG) or florbetapir (AV45)
has been proved effective in the diagnosis of Alzheimer's disease. However, the expensive …

Abnormal α-synuclein (α-syn) aggregation characterizes α-synucleinopathies, including
Parkinson's disease (PD) and multiple system atrophy (MSA). However, no suitable positron …

Alzheimer's disease (AD) is the main cause of dementia, with its diagnosis and management
remaining challenging. Amyloid positron emission tomography (PET) has become …

Alzheimer's disease (AD) is the most common cause of dementia in the elderly, affecting
roughly half of those over the age of 85. We briefly discussed the risk factors, epidemiology …

Individuals with neurocognitive disorders present with problems of memory loss, language
impairment, visuospatial difficulties, perceptual abnormalities, apraxias, attention/executive …

Abstract Purpose Pittsburgh Compound-B (11C-PiB) and 18F-florbetapir are amyloid-β (Aβ)
positron emission tomography (PET) radiotracers that have been used as endpoints in …

While the rulers of Angkor projected their power to varying degrees throughout central and
eastern mainland Southeast Asia, their most significant achievement was creating and …